Evaluation of Robotic Arm Rehabilitation in Stroke Patients
Study Details
Study Description
Brief Summary
The purpose of this study is to compare 2 training programs using robotic exercise devices to supervised arm exercises in stroke patients with chronic stable deficits.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
A robotic exercise device has been developed(MIT-MANUS)capable of providing therapy to the arm for patients with weakness due to stroke. The randomized trial will compare conventional care, planar robot intervention and an intervention of planar and vertical robot training among patients with chronic, stable deficits. We will evaluate motor outcomes, effectiveness, cost, patient satisfaction and quality of life. The study will determine the efficacy of upper extremity robot therapy compared to supervised self-administered exercise therapy in patients with deficits due to stroke.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Arm 1 Robot Exercise Group |
Device: Robotic Upper Extremity Neurorehabilitation
Upper extremity exercise using a planar robot Upper extremity exercise using a planar and vertical robot
|
Active Comparator: Arm 2 Traditional Upper Extremity Exercise Group |
Other: Traditional Upper Extremity Exercise Group
Upper extremity stretching, skateboard reaching activities, and arm ergometer
|
Outcome Measures
Primary Outcome Measures
- Upper Extremity Portion of the Fugl-Meyer Motor Performance Assessment [Baseline to Final Training (6 weeks)]
The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia (Fugl-Meyer, Jaasko, Leyman, Olsson, & Steglind, 1975; Gladstone, Danells, & Black, 2002). Sections can be administered separately and the upper extremity motor portion of this measure was used as our primary outcome. Assessment items included movement, coordination, and reflex action of the shoulder, elbow, forearm, wrist, and hand. These items were scored on the basis of ability to complete using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully. The total possible score for the upper extremity is 66 with a minimum range of 0 and maximum of 66. A higher score indicates a better outcome.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Subjects must have a clinically, defined, unilateral, hemiparetic stroke with radiologic exclusion of other diagnoses
-
Stroke onset greater than six months before randomization for ischemic stroke patients and one year before randomization for hemorrhagic stroke patients
-
A grade 3 or lower in Manual Muscle Test in the hemiparetic elbow flexion and shoulder abduction
Exclusion Criteria:
-
Subjects unable to give informed consent
-
Serious complicating medical illness
-
Contracture or orthopedic problems limiting the range of joint movement in the study arm
-
Visual loss
-
Stroke occurred within 6 months for ischemic stroke patients, one year for hemorrhagic patients
-
Botox treatment within 3 months of enrollment
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | VA Maryland Health Care System, Baltimore | Baltimore | Maryland | United States | 21201 |
Sponsors and Collaborators
- US Department of Veterans Affairs
Investigators
- Principal Investigator: Christopher Bever, MD, VA Maryland Health Care System, Baltimore
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- B3833-R
Study Results
Participant Flow
Recruitment Details | 147 community-dwelling adults with a diagnosis of chronic stroke were referred for study criteria screening by local VA stroke clinics and PT/OT clinicians. Community study advertisements and flyers were also utulized during this recruitment period that started October 2006 and ended December 2009. |
---|---|
Pre-assignment Detail | Participants were excluded prior to randomization if they did not meet inclusion/exclusion criteria. Some candidates declined after learning of the study length and schedule committment. |
Arm/Group Title | Planar Robot | Planar + Vertical Robot | Intensive Conventional Exercise |
---|---|---|---|
Arm/Group Description | Robot-assisted planar reaching x 60 minutes | Robot-assisted planar and robot-assisted vertical reaching x 60 minutes | Upper extremity stretching, skateboard reaching activites, range of motion and arm ergometer x 60 minutes. |
Period Title: Overall Study | |||
STARTED | 20 | 21 | 21 |
COMPLETED | 17 | 16 | 19 |
NOT COMPLETED | 3 | 5 | 2 |
Baseline Characteristics
Arm/Group Title | Planar Robot | Planar + Vertical Robot | Intensive Conventional Exercise | Total |
---|---|---|---|---|
Arm/Group Description | Robot-assisted planar reaching x 60 minutes. | Robot-assisted planar and robot-assisted vertical reaching x 60 minutes. | Upper extremity stretching, skateboard reaching activities, range of motion, and arm ergometer training x 60 minutes. | Total of all reporting groups |
Overall Participants | 20 | 21 | 21 | 62 |
Age (Count of Participants) | ||||
<=18 years |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Between 18 and 65 years |
16
80%
|
17
81%
|
19
90.5%
|
52
83.9%
|
>=65 years |
4
20%
|
4
19%
|
2
9.5%
|
10
16.1%
|
Age (years) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [years] |
57
(12)
|
60
(13)
|
56
(6.3)
|
57
(11)
|
Sex: Female, Male (Count of Participants) | ||||
Female |
8
40%
|
9
42.9%
|
11
52.4%
|
28
45.2%
|
Male |
12
60%
|
12
57.1%
|
10
47.6%
|
34
54.8%
|
Region of Enrollment (participants) [Number] | ||||
United States |
20
100%
|
21
100%
|
21
100%
|
62
100%
|
Fugl-Meyer Upper Extremity Motor Assessment (units on a scale) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [units on a scale] |
20.3
(14.7)
|
16.5
(10.6)
|
18.2
(12.5)
|
18.0
(12.5)
|
Outcome Measures
Title | Upper Extremity Portion of the Fugl-Meyer Motor Performance Assessment |
---|---|
Description | The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia (Fugl-Meyer, Jaasko, Leyman, Olsson, & Steglind, 1975; Gladstone, Danells, & Black, 2002). Sections can be administered separately and the upper extremity motor portion of this measure was used as our primary outcome. Assessment items included movement, coordination, and reflex action of the shoulder, elbow, forearm, wrist, and hand. These items were scored on the basis of ability to complete using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully. The total possible score for the upper extremity is 66 with a minimum range of 0 and maximum of 66. A higher score indicates a better outcome. |
Time Frame | Baseline to Final Training (6 weeks) |
Outcome Measure Data
Analysis Population Description |
---|
The number of participants analyzed were based on an intention to treat methodology with the exception of individuals that were non-compliant with the protocol or did not progress to the midpoint (3 week) evaluation. |
Arm/Group Title | Planar Robot | Planar + Vertical | Intensive Conventional Exercise |
---|---|---|---|
Arm/Group Description | Planar Robot Exercise x 60 minutes. | Planar + Vertical Robot Exercise x 60 minutes. | Upper extremity stretching, skateboard reaching activities, range of motion, and arm ergometer training x 60 minutes. |
Measure Participants | 20 | 21 | 21 |
Mean (Standard Deviation) [units on a scale] |
3.27
(3.27)
|
2.51
(3.33)
|
1.82
(4.24)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Planar Robot, Planar + Vertical, Intensive Conventional Exercise |
---|---|---|
Comments | An analysis of all robot interventions compared with intensive conventional exercise for Fugl-Meyer change were completed using linear mixed models. | |
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | .025 |
Comments | P value was set at .025 to adjust for 2 treatment comparisons and for interim monitoring for the treatment effect. | |
Method | Mixed Models Analysis | |
Comments |
Adverse Events
Time Frame | Adverse event data was collected over a 6 month time period for each participant which included baseline testing, intervention and retention. | |||||
---|---|---|---|---|---|---|
Adverse Event Reporting Description | ||||||
Arm/Group Title | Planar Robot | Planar + Vertical Robot | Intensive Conventional Exercise | |||
Arm/Group Description | Planar Robot Exercise Group | Planar + Vertical Robot Exercise Group | Upper extremity stretching, skateboard reaching activities, range of motion and arm ergometer training. | |||
All Cause Mortality |
||||||
Planar Robot | Planar + Vertical Robot | Intensive Conventional Exercise | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | / (NaN) | |||
Serious Adverse Events |
||||||
Planar Robot | Planar + Vertical Robot | Intensive Conventional Exercise | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/20 (0%) | 0/21 (0%) | 0/21 (0%) | |||
Other (Not Including Serious) Adverse Events |
||||||
Planar Robot | Planar + Vertical Robot | Intensive Conventional Exercise | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 2/20 (10%) | 1/21 (4.8%) | 1/21 (4.8%) | |||
General disorders | ||||||
Hospitalization | 2/20 (10%) | 2 | 1/21 (4.8%) | 1 | 0/21 (0%) | 0 |
Musculoskeletal and connective tissue disorders | ||||||
Shoulder pain | 0/20 (0%) | 0 | 0/21 (0%) | 0 | 1/21 (4.8%) | 1 |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. Susan S. Conroy |
---|---|
Organization | VA Maryland Health Care System, Baltimore |
Phone | (410) 605-7000 ext 3213 |
susan.conroy@va.gov |
- B3833-R